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Abstract
The neurotransmitter serotonin (5-HT) plays an important role in both the peripheral and central nervous systems. The
biosynthesis of serotonin is regulated by two rate-limiting enzymes, tryptophan hydroxylase-1 and -2 (TPH1 and TPH2). We
used a gene-targeting approach to generate mice with selective and complete elimination of the two known TPH isoforms.
This resulted in dramatically reduced central 5-HT levels in Tph2 knockout (TPH2KO) and Tph1/Tph2 double knockout (DKO)
mice; and substantially reduced peripheral 5-HT levels in DKO, but not TPH2KO mice. Therefore, differential expression of
the two isoforms of TPH was reflected in corresponding depletion of 5-HT content in the brain and periphery. Surprisingly,
despite the prominent and evolutionarily ancient role that 5-HT plays in both vertebrate and invertebrate physiology, none
of these mutations resulted in an overt phenotype. TPH2KO and DKO mice were viable and normal in appearance.
Behavioral alterations in assays with predictive validity for antidepressants were among the very few phenotypes
uncovered. These behavioral changes were subtle in the TPH2KO mice; they were enhanced in the DKO mice. Herein, we
confirm findings from prior descriptions of TPH1 knockout mice and present the first reported phenotypic evaluations of
Tph2 and Tph1/Tph2 knockout mice. The behavioral effects observed in the TPH2 KO and DKO mice strongly confirm the
role of 5-HT and its synthetic enzymes in the etiology and treatment of affective disorders.
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Introduction
The neurotransmitter serotonin (5-HT) has been implicated in a
variety of physiological functions in both the peripheral and
central nervous systems. In mammals, serotonergic neurotrans-
mission regulates a wide variety of neurobehavioral processes,
including cognition, affective states, ingestive behavior, motor
control, and sensorimotor integration [1–6]. Serotonin is also an
important modulator of the gastrointestinal system via the enteric
nervous system [7]. Given the wide range of functions that it
modulates, one might expect the depletion of 5-HT to have serious
consequences for development and maintenance of viability: in
fact some evidence exists that peripheral serotonin is important for
proper embryonic development [8].
Impaired or altered 5-HT neurotransmission appears to be a
central dysfunction leading to depressive and anxiety symptoms.
Mutations in TPH2 have been associated with a number of such
disorders and the data is controversial [9–14]. Moreover, a
number of primary therapeutics for depression, anxiety, and some
neurological conditions, such as emesis and irritable bowel
syndrome, affect the activity of the 5-HT system [15–17].
5-HT is synthesized in two steps from the amino acid
tryptophan with tryptophan hydroxylase (TPH) being the rate-
limiting enzyme. Until recently it was thought that only one
isoform of TPH existed. However, genetic deletion of the
classical enzyme did not appreciably reduce 5-HT content in
the brain, spurring a successful search for an additional
enzyme [18]. It is now established that two isoforms exist.
Tryptophan hydroxylase-1 (TPH1), the long-recognized iso-
form, is responsible for the synthesis of most peripheral 5-HT,
whereas tryptophan hydroxylase-2 (TPH2) is neuronal specific
[19,20] and therefore likely to control most central 5-HT
synthesis.
We used a gene-targeting approach to generate mouse lines
lacking either Tph1 or Tph2, and then crossbred the two lines to
produce animals lacking both genes. Here we report findings from
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knockout (DKO) mice. To our knowledge this is the first report
with full phenotypic evaluation of mice with genetic deletion of
Tph2 and of both Tph isoforms.
Materials and Methods
Generation of TPH1, TPH2 and TPH1/TPH2 deficient
animals
We constructed the Tph1 (NM_009414) and Tph2
(NM_173391) targeting vectors from the lambda KOS
TM system
[21]. The yeast selection cassette was generated by PCR to include
mouse genomic sequences flanking the region of deletion and
introduced into the respective mouse genomic clone by yeast
recombination. Homologous recombination resulted in the
deletion of coding exon 2 of Tph1 and coding exons 1 and 2 of
Tph2. The Not1-linearized targeting vector was electroporated into
129S5/SvEvBrd embryonic stem (ES) cells. G418/FIAU resistant
ES targeted clones were isolated and confirmed by southern
hybridization on both arms of homology with gene specific probes.
In addition a Neo probe was used to screen for random insertion
events. Targeted ES clones of each deletion were independently
injected into C57BL/6J-Tyr
c-Brd (albino) blastocysts and the
resulting chimeras were mated to C57BL/6J-Tyr
c-Brd females to
generate F1 heterozygous mice for each KO line. For single gene-
deletion phenotypic analyses, the F1 heterozygous progeny are
intercrossed to generate F2 wild type (WT), heterozygous (Het),
and homozygous (KO) progeny for each of the two Tph genes.
WT, Het, and KO progeny were obtained in normal Mendelian
ratios (1:2:1) for each of the Tph genes.
To generate Tph1/Tph2 DKO mice, Tph1 KO males were bred
with Tph2 Het females. Animals heterozygous for both loci were
selected from the progeny, and subsequent breeding of double
heterozygotes was undertaken to produce DKO animals, which
were recovered at Mendelian ratios (one in sixteen).
All experiments described below were carried out with protocols
approved by The Institutional Animal Care and Use Committee
of Lexicon Pharmaceuticals.
Genotyping
Genotyping of tail DNA by PCR was conducted according to
standard protocols [22]. TPH1KO mice were genotyped with the
following primers: P1: 59ACC ACC TTC TTC CTC CTT TTG
AGC 39 and P2: 59 CCG GGA GAT CTG TGA AGA GTT
TGG 39 that generated a 654 bp PCR product in the WT (+/+)
and Het. Mutant specific strategy produced a 483 bp amplicon in
the Het and Hom with the following primer pair: P3: 59 GCA
GCG CAT CGC CTT CTA TC 39 and P4: 59 CCG GGA GAT
CTG TGA AGA GTT TGG 39.
To genotype TPH2KO mice we used the following primer
pairs: for wild type band (+/+) P5: 59TTA TTA CCC ACA AAC
GCT GAA 39 and P6:59GTT TAT GCT GGC ACT GGT ACT
TGA 39 that generated a 348 bp amplicon; for the mutant band
P7: 59GCA GCG CAT CGC CTT CTA TC 39 and P8: 59CCT
TAA TGA CAG GGA ACA AGT C 39 generated a 235 bp PCR
product.
DKO mice were genotyped with the same primer sets as was
used for each individual gene KO in a multiplex reaction.
Subjects
Animals used for all studies were male and female KO or DKO
and WT cohort mates bred in a mixed (C57BL/6J-Tyr
c-
Brd6129S5/SvEvBrd) genetic background at Lexicon Pharmaceu-
ticals. All mice were maintained under a standard light/dark cycle
from 7 am to 7 pm. They were housed in groups of five in
30620620 cm acrylic cages with food and water freely available.
For TPH1KO the cohort consisted of 12 female KO, 18 male
KO, 10 female WT and 6 male WT. This cohort was run through
a standard phenotypic analysis battery used at Lexicon Pharma-
ceuticals (as an example, the phenotypic screen of VGLUT1 mice
is accessible at: http://www.informatics.jax.org/external/ko/
lexicon/2383.html). For TPH2KO there were three separate
cohorts of mice used in the experiments. Cohort 1 was run
through a comprehensive phenotypic analysis and consisted of 4
male and 4 female mice per genotype. Cohort 2 consisted of 11
female KO, 6 male KO, 11 female WT and 9 male WT. Cohort 2
was tested in a standard behavioral phenotypic analysis battery at
age of 12 weeks. Cohort 3 consisted of 15 female KO, 17 male
KO, 19 female WT and 15 male WT. Cohort 3 was tested in the
marble burying, platform anxiety test, and forced swim test at 12–
14 weeks of age, and males from Cohort 3 were also tested in the
repeated tail suspension test when mice were 6 months old. Male
mice from cohort 3 were then used for detection of neurotrans-
mitter levels in different brain regions. For TPH1/TPH2 DKO
mice the cohort consisted of 12 female DKO, 6 male DKO, 9
female WT and 10 male WT and was tested in a standard
behavioral phenotypic analysis battery starting at age of 12 weeks.
Neurochemical Analysis
To analyze the contents of monoamine neurotransmitters in
various regions of the brain mice were sacrificed for tissue dissection.
The olfactory bulb, cerebellum, brainstem, hippocampus, striatum,
cortex, and thalamus with hypothalamus were dissected out and
frozen immediately on dry ice. The brain tissues were subsequently
homogenized in 46volume (i.e. 4 mL of buffer for each mg of tissue)
of ice-coldbuffer (0.1 M trichloroaceticacid, 10 mMsodium acetate,
0.1 mM EDTA, pH 3.7) in glass homogenizers. The homogenates
were transferred to an Eppendorf tube and centrifuged at 180006g
at 4uC for 5 min. The supernatants were collected and passed
through a 0.22 mm filter column and then through a filter column
with a molecular weight cutoff at 10K (Nanosep 10K; Pall Life
Sciences, East Hill, NY) by centrifugation at 180006ga t4 uC. To
analyze the contents of dopamine, norepinephrine, serotonin and
theirmetabolites in the tissue extracts,15 mL of the extract from each
tissue was injected into an HPLC system (Waters 515 pump, Water
Corporation, Milford, MA) with an C18 column (MD-150 C18
column,ESAInc.,Chelmsford,MA)and anelectrochemicaldetector
(Coulochem III, ESA Inc., Chelmsford, MA).
Peripheral 5-HT levels
Mice were anesthetized using isoflurane during blood draw via
cardiac puncture and then sacrificed by rapid decapitation. Mid-
jejunum and entire colon were isolated, mesenteric fat removed,
gut lumen opened and blotted dry, and tissues frozen immediately
in liquid nitrogen and stored at 280 C for further analysis. 5-HT
was extracted from the tissues by homogenizing in a buffer
containing 300 mM trichloroacetic acid, 100 mM sodium acetate,
pH 3.5, 10 mM EDTA, and 20 mM sodium bisulfate. The
homogenates were centrifuged and supernatants analyzed for 5-
HT content using an HPLC method.
Histology
Tissues were collected from TPH1KO (n=8; 18–20 weeks of age),
TPH2KO (n=2; 16 weeks of age) and DKO mice (n=2 ;4 9t o5 1
weeks of age) as well as age-matched WT mice and were fixed by
immersion in 10% neutral buffered formalin. All tissues were
embedded in paraffin, sectioned at 4 mm, and mounted on positively
charged glass slides (Superfrost Plus, Fisher Scientific, Pittsburgh, PA)
Life without Serotonin
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examination. For the full list of tissues examined see Table S1.
DEXA analysis
Mice were anesthetized by intraperitoneal injection of Avertin
(1.25% 2,2,2,-tribromoethanol, 20 ml/kg body weight ), measured
body length and weight, and then placed in a prone position on
the platform of the PIXImus
TM Densitometer (Lunar Inc.) for a
DEXA scan. Using a Lunar PIXImus software, the Bone mineral
density (BMD) and fat composition (% fat) and total tissue mass
(TTM) were determined in the regions of interest (whole body,
vertebrae, and both femurs).
Behavior assays
Mice were tested in a standardized behavioral phenotyping
battery. A comprehensive phenotypic analysis (including a subset
of behavioral tests derived from the Irwin screen) revealed no
notable abnormalities across a wide range of behaviors as well as
assays for cardiac, immune system, endocrine, and ophthalmic
function (for the full list of assays see Table S2). Methods not
described in the main text are available in Methods S1.
Locomotor activity. Locomotor and exploratory behaviors
were recorded with twelve Digiscan open field (OF) apparatus and
Versamax software, v.4.00-127E (Accuscan Instruments, Inc.,
Columbus, OH). A large arena (42 cm642 cm) with infrared
beams at three different levels was used to record horizontal
locomotor activity (total distance), vertical movement (rearing),
and investigation into the 4 holes in the floor of the open-field
(hole poke). Two florescent lamps positioned over each chamber
provided light levels of 800 lux in the center of each open field
arena. Each animal was placed in the center of the open field and
its activity was measured for 20 min. The total distance traveled
(cm), vertical movement number (rearing), number of hole pokes,
time spent in the center of the OF (time-in-center), distance
traveled in the center of the OF (center distance), and center/total
distance ratio over the intervals were recorded using Versadat
program, v.2.70-127E (Accuscan Instruments). The OF center
area measured 20620 cm.
Marble burying test. The marble burying test for anxiety-
related and compulsive-like behaviors was performed as previously
described [23]. Mice were individually placed into cages
(24618613 cm) filled to a depth of 5 cm with clean bedding for
a 30-min testing period. Prior to each testing round, the
experimenter evenly spaced 25 identical marbles across the
bedding surface. 16 mice were examined in separate cages
during each testing round. After 30 min, each mouse was
returned to its home cage and all marbles 2/3 or more covered
by bedding were scored as buried by an experimenter blind to
genotype.
Hot Plate test to assess nociceptive response to an acute
thermal pain stimulus was performed using a Columbus
Instruments Hotplate Analgesia meter model 1440 (Columbus,
OH). The hot plate was set to 55u C and controlled to within 0.1u
C. The size of the heated surface area was 100610060.750. The
response time for each animal (hind-paw flinching) was recorded
by the experimenter (blind to test subject genotype).
Tail Suspension test. The tail suspension test for depression-
related behavior was conducted using 8 chambers from Med
Associates Inc (PHM-300TSS Mouse Tail Suspension System,
Med Associates, Georgia, VT). The mouse was securely fastened
with medical adhesive tape by the tip (,1.0–1.5 cm) of the tail to a
metal hanger and suspended above the floor in a visually isolated
cubicle. The data was recorded using Med Associates Tail
Suspension software version 2 (Med Associates, Georgia, VT).
Immobility was defined as the area under the curve using an
immobility threshold of 2. The total duration of immobility over a
single 6-min session was recorded for each mouse. For Tph2 KO
male mice the test was repeated for three days. Animals that
climbed their tails during testing on any of the test days were
excluded from data analysis.
Forced swim test. The FST chamber was a 2000 ml Pyrex
beaker with a diameter of 14 cm filled with deionized water (25uC)
to a depth of 14 cm. A black Plexiglas chamber
(30 cm628 cm620 cm) surrounded each beaker. The front and
top of the chambers were open to allow for video recording. To
optimize contrast, a black background was used for white mice,
and a white background was used for agouti and black mice. With
respect to the forced swim test, our in-house experience showed
that measuring immobility for one six-minute session (standard
mouse one-day protocol) is not sufficient to detect an
antidepressant-like effect for certain antidepressants. We
therefore employed a 2-day protocol similar to that commonly
used for rats [24,25] and found this to enhance the sensitivity of
the test [26].
On the first testing day mice swam for 15 min (pre-test session).
Twenty four hours later, mice were exposed to the same
experimental conditions for 5 min (test session). The water in
the beaker was changed between each animal. The data was
analyzed with image analysis software, VideoTrack Quantization
(ViewPoint Life Sciences, Montreal, QC, Canada) and immobility
and struggling were quantified for the duration of the first 5 min
during pre-test (so that we also have data comparable to the
standard one-day mouse FST) and all 5 min during the test
session. Immobility was defined as minimal movements required
for a mouse to keep its head above the water. Struggling was
defined as vigorous movements with forepaws breaking the water.
The same thresholds were set for all animals (,450 was considered
immobility; .785 was counted as struggle). Swimming was
defined in the program as activity measuring between thresholds
450 and 785, but was not used in analyses as it represented the
difference between total test time and measures for immobility,
and struggling.
Data analysis
Results are presented as individual data points or as means +/2
S.E.M. The Statistica 7.0 software package (StatSoft, Inc., Tulsa,
OK) was used to determine significant differences between groups.
The data was analyzed with one-way ANOVA tests with genotype
and sex (where both sexes were tested) as main effects. Tukey’s
HSD or Dunnett’s post hoc analyses were used when main effects
or interactions were significant. Unpaired two-tailed t-tests were
used to compare genotypes when data from males and females was
analyzed separately, and where animals of only one sex were
tested. The data for OF and repeated tail suspension tests was
analyzed using repeated measures ANOVA with genotype and sex
as main effects, and test interval or day as a repeated measure.
Results
A homologous recombination deletion strategy was utilized to
replace coding exon 2 of Tph1 (Fig. 1A) and coding exons 1 and 2
(Fig. 1B) of Tph2 with a LacZ/neomycin resistance gene cassette.
G418/FIAU resistant ESC clones for Tph1 deletion were analyzed
by southern hybridization of SpeI (s) digested genomic DNA blot
with a 244 bp 59 external probe (Fig. 1A) generated using: 59GCT
CTT CTA AAA CGT CCA GTA G 39 and 59GTC TGA GTA
AGA TTA AAC AAT CCG 39 as primer pairs. This 59 external
probe labeled a 9.238 kb band in SpeI digested WT genomic
Life without Serotonin
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DNA (Fig. 1C). G418/FIAU resistant ES-cell clones for TPH2
deletion were analyzed by southern hybridization with a 217 bp
39external probe (Fig. 1B) generated using the following primers;
forward 59ACA TAC CAA TTC AAC CCA ATG 39 and reverse
59AGA GGG AAG ATG CCA CAT AGA T 39. This external
probe labeled a 12.526 kb band in Bgl1 (b) digested WT genomic
DNA and a 5.888 kb band in the deletion mutant (Fig. 1D). The
germline male chimeric mice were crossed with C57BL/6J female
mice to generate the single gene homozygous, heterozygous and
WT offspring as confirmed by PCR analysis (Fig. 1 E, F).
Subsequent breeding was undertaken to produce double hetero-
Figure 1. Generation and confirmation of TPH1, TPH2 and TPH1/TPH1 deficient animals. (A) Genomic organization of exon 1 and exon 2 of
TPH1 gene (WT), the targeting construct (Vector), and the mutant allele (Null). The MC1 Neo selection cassette replaces exon 2 by homologous
recombination. The recombined allele is shown as the null allele with the restriction enzyme of choice Spe1 (s) and the 59 external probe (black bar)
used for southern hybridization. (B) Genomic organization of exon 1 and exon 2 of TPH2 gene, the targeting vector construct, and the mutant allele.
The MC1 Neo selection cassette replaces exons 1 and 2 by homologous recombination. The recombined allele is shown as the null allele with the
restriction enzyme of choice Bgl1 (b) and the external probe (black bar) used for southern hybridization. (C) TPH1 targeted ESC genomic DNA was
restriction digested with Spe1 and hybridized with the 59 external probe to show the wild type (+/+) 9.2 kb band and the mutant band (+/2)a t
5.9 kb in the heterozygous ES cells. (D) Targeted ES cell genomic DNA was restriction digested with Bgl1 (b) and hybridized with the 39 external probe
to show the wild type (+/+) 12.5 kb band and the mutant band (+/2) at 5.9 kb in the heterozygous ES cells. (E) The pups were genotyped by isolating
tail genomic DNA and PCR amplifying sequences using specific TPH1 primers that amplified a 654 bp product in the wildtypes (+/+) and hets (+/2)
and primers specific to the deletion insertion that produced a 483 bp product in the Hets (+/2) and the Homs (2/2). (F) The TPH2 null pups were
genotyped by isolating tail genomic DNA and PCR amplifying sequences using specific primers that amplified a 348 bp product in the wildtypes (+/+)
and hets (+/2) and primers specific to the deletion insertion that produced a 235 bp product in the Hets (+/2) and the Homs (2/2). (G) The DKO
pups were genotyped with the TPH1 and TPH2 specific primers as in Fig.1E, F. Individual animals (1–5), of each relevant genotype is shown: 1) TPH1
+/
+/TPH2
+/+; 2) TPH1
+/2/TPH2
+/2, 3) TPH1
+/2/TPH2
2/2; 4) TPH1
2/2/TPH2
+/2, 5) TPH1
2/2/TPH2
2/2. 100 bp molecular weight markers are also indicated.
doi:10.1371/journal.pone.0003301.g001
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PLoS ONE | www.plosone.org 5 October 2008 | Volume 3 | Issue 10 | e3301zygotes which were bred to generate double knockouts deleting
both Tph1 and Tph2 genes as confirmed by genotyping analysis
(Fig. 1G).
TPH2KO and DKO mice were analyzed by HPLC for levels of
monoamine neurotransmitters and their metabolites in various
regions of the brain. Levels of 5-HT and its metabolite, 5-HIAA,
were dramatically reduced in all brain regions examined both in
TPH2KO and DKO animals (Table 1). Reduction of 5-HT in
TPH2KO mice ranged from 67.5% (cerebellum) to 96.9%
(striatum), while 5-HT reduction in DKO mice ranged from
94.4% (cerebellum) to 99.2% (cortex). 5-HT levels were lower in
DKO mice than in TPH2KO mice in all brain regions examined.
The percentage of 5-HIAA reduction paralleled changes in 5-HT.
No generalized changes were noted in other neurotransmitter
levels (Table 1).
Mice were also analyzed for peripheral 5-HT (Table 2). In
TPH1KO mice 5-HT levels in blood, jejunum, and colon were
strongly reduced, as expected [27]. TPH2KO mice did not differ
significantly from WT mice in peripheral 5-HT levels. In DKO
mice 5-HT was greatly reduced in these peripheral tissues.
These changes in 5-HT and 5-HIAA levels demonstrate a
marked disruption of brain 5-HT homeostasis in TPH2KO and
DKO mice. To understand the role such changes may play in the
pathophysiology of affective disorders, the mutant and WT mice
from TPH1, TPH2, and DKO lines were tested in a series of
behavioral assays selected to model different aspects of neurolog-
ical disorders. TPH2KO and DKO mice did not differ from their
WT cohort-mates in gross appearance, nor by histological analysis.
Body size, weight, and percent body fat content were examined as
a part of initial phenotypic evaluation (Table 3). Since an effect of
gender on body length and weight was significant [F(1,62).30,
Ps,0.00001], males and females were analyzed separately. In
males genotype effects were significant [F(3,27)=4.4, 8.5, and 5.2
for body length, weight, and fat content, accordingly, p-
values,0.05]. Post-hoc analysis revealed that body weight and
length were significantly decreased in TPH2KO and DKO males,
compared to WT males. In addition, DKO males also had
decreased percent of body fat as measured by DEXA. In females a
genotype effect on fat composition reached significance
[F(3,35)=6.0, p,0.01] with DKO females having significantly
less body fat than WT controls.
There was no behavioral phenotype in TPH1KO mice in any of
the assays, consistent with previously published data [19,20,28].
Therefore the behavioral data for TPH1KO mice are not
discussed further.
For the TPH2KO and DKO, there were no differences
between the KO or DKO and WT littermate control mice in
motor coordination, acoustic startle response and sensorimotor
gating, tonic inflammatory pain sensitivity, and learning and
memory as assessed in inverted screen, pre-pulse inhibition,
formalin paw, and trace fear conditioning assays, respectively
(Table 4).
Results from testing TPH2KO mice in the OF revealed that
total distance traveled did not differ between KO and WT mice
(Fig. 2A). There was a significant effect of time [F(4,128)=50.5,
P,0.00001] indicating habituation to the OF, evident in both
genotypes. There was also a sex6genotype6time interaction
[F(4,128)=2.7, P,0.05] on total distance traveled; however, no
sex differences were observed. There was a non-significant trend in
both genders for the TPH2KO to spend less time in the center
[F(1, 32)=3.35, p=0.076] and genotype6time interaction was
significant [Fig. 2B, F(4,128)=2.8, P,0.05]. There were signifi-
cant sex effects on center time and center distance in both
genotypes [F(1,32).7.5, P,0.01] with males spending more time
and traveling more distance in the center than females. There was
no difference between TPH2KO and WT mice in exploratory
behaviors such as hole-poke and rearing.
Similar to the results for the TPH2KO, there were no
significant differences between DKO and WT mice in total
distance traveled, indicating normal locomotor activity (Table 4).
None of the effects or interactions approached significance in this
data analysis. This is also consistent with the lack of differences
between genotypes in the circadian activity assay (Table 4). There
was no difference between genotypes in center time and
exploratory behaviors between DKO and WT mice.
The marble burying (novelty-induced digging) test is a valuable
screening test for the detection of compounds having anxiolytic
and/or antidepressant effects and is effective in detecting the
behavioral effects of serotonin uptake inhibitors [29,30]. In
TPH2KO cohort 2, male KO mice buried significantly more
marbles (P,0.05, data not shown). When marble burying was
repeated in TPH2KO cohort 3 homozygous mice again buried
significantly more marbles than WT mice (Fig. 3A, F(1, 61)=5.61,
P,0.05). There was no effect of sex and no genotype6sex
interaction for marble burying in TPH2KO mice. There was a
significant effect of genotype with DKO mice burying significantly
more marbles than WT mice (Fig. 3B, F(1, 33)=39.17,
P,0.0001). There was no effect of sex and no genotype6sex
interaction for marble burying in DKO mice.
Table 2. Comparison of peripheral 5-HT levels in TPH1KO,
TPH2KO and TPH1/TPH2 DKO mice (mean6S.E.M.).
Blood Jejunum Colon
mM fmol/mg fmol/mg
WT n=17 24.360.5 247636514 10713761357
TPH1KO n=4 1.660.1* 378630* 671696*
TPH2KO n=4 18.161.3 2900062700 10702562946
{
DKO n=3 1.760.1* 7366.2* NT
*5-HT levels are significantly lower than those in WT (p values#0.01, one way
ANOVA followed by Dunnett’s post-hoc test).
{n=10.
NT: Not Tested.
doi:10.1371/journal.pone.0003301.t002
Table 3. Body size, weight, and percent body fat
(mean6S.D.) in WT, TPH1KO, TPH2KO, and TPH1/TPH2 DKO
mice.
Sex/Genotype
Body Weight
(g)
Body Size
(cm) % Body Fat
Males WT (n=18) 32.8562.6 10.060.30 18.263.5
TPH1KO (n=4) 29.761.3 9.9060.11 15.762.3
TPH2KO (n=4) 27.461.3 * 9.6060.21 * 14.261.1
DKO (n=5) 29.261.7 * 9.6860.20 * 13.060.2 **
Females WT (n=21) 25.1863.9 9.4660.30 21.065.5
TPH1KO (n=2) 23.3961.6 9.360.14 15.861.9
TPH2KO (n=4) 22.462.9 9.1260.40 15.360.5
DKO (n=12) 24.462.3 9.3260.19 14.961.9 **
*p ,0.05; ** p,0.01 compared with WT (Dunnett’s post-hoc test).
doi:10.1371/journal.pone.0003301.t003
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PLoS ONE | www.plosone.org 6 October 2008 | Volume 3 | Issue 10 | e3301In the forced swim test, male TPH2KO mice exhibited trends
for decreased immobility on pre-test day (t(28)=1.9, P=0.068)
and significantly less immobility on the test day (t(28)=2.1,
P,0.05, Fig. 4A). In female TPH2KO mice only a trend in the
same direction was observed (Fig. 4B). There was no difference in
struggling behavior between TPH2KO and WT mice. DKO
males displayed less immobility on both pre-test (t(9)=2.4,
P,0.05) and test days (t(9)=6.7, P,0.0001), and also more
struggling on both pre-test (t(9)=2.4, P,0.05) and test days
(t(9)=6.4, P,0.001, Fig. 4C). DKO females also showed
significantly lower immobility on both pre-test (t(19)=3.96,
P,0.001) and test days (t(19)=2.5, P,0.05, Fig. 4D). Similar to
the males, DKO females struggled more than WT females on both
days, but the difference reached significance only on pre-test day 1
(t(19)=2.2, P,0.05). Overall, genetic disruption of TPH2 resulted
in a mild antidepressant phenotype, and this became much more
significant in the DKO mice. Visual observation of swimming
behavior suggests that DKO mice had difficulty keeping their
heads above water when not actively swimming. Video S1
showcases this inability to float in DKO mice (from left to right:
WT, DKO, DKO).
There was no significant effect of genotype in a standard one-
day tail suspension testing in either male or female TPH2KO
mice. Male mice from cohort 2 were additionally subjected to
three days of repeated tail suspension testing. The results showed
only a significant genotype6day interaction for immobility time
[F(2,46)=4.1, p,0.05), but still no genotype effect (Fig. 5A).
Analysis of interaction showed that immobility significantly
Table 4. General behavioral characterization of TPH1KO, TPH2KO and TPH1/TPH2 DKO mice.
TPH1 TPH2 TPH1/TPH2
WT KO WT KO WT KO
Circadian (only females)
First 1 hour habituation 6316296 (10) 7606241 (12) 7926100 (2) 5086291 (4) 9576189 (9) 8226350 (12)
First 10 hours habituation 273761525 (10) 27856973 (12) 23816742 (2) 23746764 (4) 378561385 (9) 408663333 (12)
Average light cycle activity 8386587 (10) 8776292 (12) 8796319 (2) 6406274 (4) 9626421 (9) 9216807 (12)
Average dark cycle activity 351462229 (10) 31856488 (12) 327362070 (2) 367961993 (4) 436761949 (9) 409962869 (12)
Open Field
Total distance (cm) 18616648 (16) 21846739 (30) 22286839 (19) 197861070 (17) 21636884 (19) 25536875 (18)
Center Time Male 3396102 (6) 2236137 (18)# 4906143 (9) 3446192 (6) 3376138 (10) 322688 (6)
Center Time Female 2336186 (10) 245695 (12) 2916158 (10) 2346161 (11) 2206132 (9) 2266143 (12)
Rearing 43.3636.4 (16) 57.6638.3 (30) 54632 (19) 61640 (17) 69.1653.2 (19) 78.3631.6 (18)
Basal Body Temperature
Female 35.660.53 (10) 35.860.75 (12) 36.160.62 (4) 36.961.0 (4) 36.460.37 (9) 36.860.45 (12)*
Male 35.060.74 (6) 35.860.6 (18)* 36.66.56 (4) 36.760.61 (4) 36.460.78 (10) 36.560.94 (6)
Stress-induced Hyperthermia
Only males 1.7860.66 (6) 1.760.73 (18) 0.8361.23 (4) 1.3360.39 (4) 1.9560.61 (10) 1.8260.94 (6)
Inverted Screen
Fell down (ratio) 0/16 (0%) 1/30 (4%) 1/8 (13%) 5/8 (63%) 1/19 (6%) 1/18 (6%)
Climbed up (ratio) 7/16 (44%) 20/30 (67%) 0/8 (0%) 6/8 (75%) 7/19 (37%) 11/18 (62%)
Hot Plate
Latency to respond, sec 7.363.2 (16) 6.762.7 (30) 9.162.0 (8) 10.163.3 (8) 6.262.9 (19) 4.061.9 (18)*
Acoustic Startle Response
120 dB 7016447 (16) 6996429 (30) 3006259 (8) 3546283 (8) 3706246 (19) 3896252 (18)
PPI (%)
pp4 26.6620.5 (15) 33619.2 (27) 29.8613.2 (7) 33.4616.8 (6) 28.3621.9 (14) 18.8630.5 (17)
pp8 31.4621.7 (15) 43.3619.2 (27) 36.7626.4 (7) 46.3616.7 (6) 29.0627.3 (14) 27.5626.2 (17)
pp12 48.8619.5 (15) 54.3620.3 (27) 47.8621.9 (7) 44.6619.3 (6) 41.9622.6 (14) 38.4624.8 (17)
pp20 57.8620.7 (15) 65.9615.2 (27) 72.7616.4 (7) 71.8611.9 (6) 62.8621.2 (14) 63.3618.7 (17)
Fear conditioning
Context freezing (%) 12.45620.6 (16) 9.5613.9 (30) n/a n/a 8.6610.9 (19) 3.667.8 (18)
Cued freezing (%) 19.4625.1 (16) 18.7621.9 (30) 26.6626.4 (8) 16.9621 (8) 17.6620.8 (19) 8.6618.7 (18)
Formalin Paw (only males)
Phase 1 flinches 251654 (6) 173666 (16)* 2536102 (4) 1656129 (4) 213683 (10) 128699 (6) #
Phase 2 flinches 6246208 (6) 4526187 (16)# 5586268 (4) 3256188 (4) 5176166 (10) 3576269 (6)
Data are expressed as mean6S.D. (N). Statistical analysis was performed for all assays. Mice with startle response below 100 were excluded from PPI analysis. * - p,0.05
from WT cohort mates (unpaired t-test); # - p=0.07–0.09.
doi:10.1371/journal.pone.0003301.t004
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PLoS ONE | www.plosone.org 7 October 2008 | Volume 3 | Issue 10 | e3301increased from day 1 to day 3 in TPH2KO (p,0.05 – immobility
on day 3, compared to day 1) but did not change in the WT.
TPH2KO tended to have higher immobility on day 3 than WT
mice (Fig. 5B). In DKO mice there was a significant effect of
genotype [F(1,26)=8.0, p,0.01] and sex [F(1,26)=6.0, p,0.05],
but no genotype6sex interaction. DKO mice had significantly
greater immobility time, compared to WT littermates (Fig. 5C).
Female mice of both genotypes had higher immobility time than
males.
Serotonergic systems are involved in the central regulation of
nociceptive sensitivity. In our experiments there was no difference
between TPH2 and DKO mutants and WT cohort-mates in tonic
pain sensitivity assessed by formalin paw test (Table 4). There was
no significant difference between genotypes for TPH2 KO mice in
hot plate model. However, DKO mice exhibited altered pain
sensitivity to an acute thermal stimulus. There was a significant
effect of genotype with DKO having a lower latency to respond
(Fig. 6, F(1,33)=5.68, p,0.05). There was no effect of sex and no
genotype6sex interaction for latency to respond on the hot plate in
DKO mice. This data indicates that DKO mice had increased
sensitivity to acute nociception in the hot plate assay.
Discussion
When TPH1 was first genetically deleted in mice, it was
generally expected this would result in homozygous lethality [20].
Surprisingly, those TPH1 homozygote mice appeared largely
normal in appearance and behavior. Our results escalate this
surprise further as genetic deletions of the neuronal enzyme TPH2
and the combination of TPH1 plus TPH2 enzymes also produced
viable mice with relatively subtle alterations in behavior. The
results dramatically indicate that 5-HT is not essential for overall
development and that its role in behavior is modulatory rather
than essential.
Initial phenotypic analysis of these mutants revealed no
differences in a range of measures of physical health including
assays for cardiac, immune system, endocrine, and ophthalmic
function (unpublished observations). TPH2KO and DKO mice
also did not differ from their WT cohort-mates in gross
appearance, however TPH2KO and DKO males were smaller
in body length and weight, and DKO males and females had
significantly lower fat content, compared to WT controls. Recently
Gutknecht et. al. [31] have reported similar general phenotypic
observations of their TPH2 KO animals with detailed histological
analysis showing no loss of serotonergic cells in the raphe nucleus
of the brain in spite of total loss of 5-HT. Our data on the 5-HT
level from TPH1KO mice [27] are consistent with results from a
previous report [18], with blood and intestinal 5-HT levels greatly
reduced, yet no alteration in 5-HT in the brain. TPH2KO mice
did not differ significantly from WT mice in peripheral 5-HT
levels, however levels of 5-HT and its metabolite, 5-HIAA, were
strongly reduced in all brain regions examined. In DKO mice 5-
HT levels were dramatically reduced in both peripheral and brain
tissues. These data confirm the widely held hypothesis that TPH1
Figure 2. Open Field total distance (A) and center time (B) in
TPH2KO mice. M – males, F- females.
doi:10.1371/journal.pone.0003301.g002
Figure 3. Marble burying test. Male and female data combined
on the plots since one-way ANOVA did not reveal significant
effect of sex or sex6genotype interactions. (A) Marble burying in
TPH2KO mice. Males: 15 WT, 16 KO; females: 19 WT, 15 KO. (B) Marble
burying in TPH1/TPH2 DKO mice. Males: 10 WT, 6 DKO; females: 9 WT,
12 DKO. * P,0.05 compared to WT mice, ** - p,0.0001 compared to
WT mice.
doi:10.1371/journal.pone.0003301.g003
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peripheral tissues and in the central nervous system, respectively.
TPH2KO and DKO animals appear to contain residual 5-HT
in the brain. In the TPH2KO mice this may represent inadvertent
contamination from blood. However, small amounts were also
seen in the DKO animals where peripheral 5-HT levels were
negligible. It is possible this apparent 5-HT is due to another
neurochemical with HPLC mobility very similar to 5-HT or to
tryptophan hydroxylase-like activity by another enzyme such as
phenylalanine hydroxylase [32].
Genetic deletion of 5-HT synthesis did not affect locomotion or
exploratory behavior as no differences were found in the open field
test, inverted screen, and circadian activity of all three mutants
tested and compared to their WT cohort-mates. The trend for the
reduction in center time in the TPH2KO may be an indicator of
increased anxiety. Whole brain 5-HT levels are also reduced,
almost 70%, in serotonin transporter (SERT) KO mice. Reduced
activity and increased anxiety-like behavior was observed in the
SERT KO mice in the novel open field, elevated plus-maze and
light/dark exploration test [33,34]. This is somewhat consistent
with the findings in the present study although the SERT KO
phenotype was more robust.
Compounds having anxiolytic or antidepressant effects alter
behavior in MB, reducing the number of marbles that become
buried [30,35]. Acute treatment with pharmacologic inhibitors of
SERT, selective serotonin reuptake inhibitors (SSRI) and less
specific uptake inhibitors, results in a decreased number of marbles
buried and is presumed to be indicative of their antidepressant or
anxiolytic activity [29,36]. Genetic deletion of SERT results in
mice that bury fewer marbles [34]. The interpretation of increased
marble burying found in the present study is not clear, but has
been suggested to be a measure of obsessive/compulsive behavior
rather than anxiety-like behavior [37]. It is possible that
abnormality of this form of behavior, rather than altered anxiety,
accounts for the increased marble burying in TPH2 and TPH1/
TPH2 DKO mice.
Considering the established involvement of serotonergic mech-
anisms in the pathophysiology of depression, we evaluated the
depressive-like behavior of mice in two common animal models
used for antidepressant screening: the forced swim test (FST) and
tail suspension (TS). The direction of effects in FST and TS were
opposite in the KO animals, FST suggesting an antidepressant-like
effect and TS exhibiting what might be a prodepressive-like effect.
Visual observation suggests that DKO mice had difficulty keeping
their heads above water when not swimming. This inability to float
may contribute to the apparent antidepressant phenotype in the
FST and explain the opposite direction of effects in the two tests. It
is interesting to speculate whether the reduced body fat, therefore
increased body density, in the DKO contributes to this difference
in floating behavior.
In addition, although both TS and FST tests hold high
predictive validity for potential antidepressants, they are not
synonymous because distinct neurochemical and neuroanatomical
pathways are involved [38,39,40]. Of particular relevance, FST
produces a variation of the monoamine concentration in the brain
while TS does not [40,41]. In addition, serotonin and dopamine
concentrations increased after FST, but no changes in neuro-
transmitter concentrations were observed after TS [40]. There are
also inter-strain differences in mouse performance in these tests.
For example, in NIH-Swiss mice, a seven-fold difference in
baseline immobility was observed between the FST and TS. By
contrast, the baseline immobility in C57Bl/6 mice was similar in
both procedures. Also the antidepressant-like activity of various
classes of antidepressants was only detected using the NIH-Swiss
Figure 4. Immobility and struggling in the forced swim test. (A) TPH2KO Males. (B) TPH2KO Females. (C) TPH1/TPH2 DKO Males. (D) TPH1/
TPH2 DKO Females. *** - p,0.001, ** - P,0.01, * - p,0.05 compared to WT mice (unpaired t-test).
doi:10.1371/journal.pone.0003301.g004
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reported for serotonin transporter (SERT) KO mice on a 129 or
C57BL/6Jx129S6 mixed genetic background [34,42]. However,
SERT KO mice backcrossed onto a C57BL/6J background were
normal in acute testing in TS and FST [33]. In a recent report, a
TPH2 knockin mouse line with reduced TPH2 activity and an
80% reduction in brain 5-HT, due to a rare human SNP (R441H),
was reported to have significantly increased immobility times in
the TS [43].
Serotonergic systems are involved in the central regulation of
nociceptive sensitivity. Whether 5-HT has an analgesic or
hyperalgesic action depends on the cell type and type of receptor
it is acting through. In the periphery, 5-HT sensitizes afferent
nerve fibers, thus contributing to hyperalgesia in inflammation and
nerve injury [44]. Antidepressant drugs are reported to be used as
co-analgesics in clinical management of migraine and neuropathic
pain [45,46]. Several studies have reported that a selective
serotonin reuptake inhibitor, fluoxetine, produces an antinocicep-
tive effect in pain assays, including the hot plate test [47,48]. In our
experiments, DKO animals exhibited altered pain sensitivity to an
acute thermal stimulus in the hot plate model supporting 5-HT
involvement in the regulation of pain.
In summary, the present study shows that genetic deletion of
TPH2 strongly reduces the amount of 5-HT and 5-HIAA in the
brain, but does not reduce their levels in the periphery. This is
consistent with evidence that TPH2 is the primary synthetic
enzyme in the brain, while TPH1 is responsible for 5-HT synthesis
in extraneuronal tissues. The combined deletion of TPH1 and
TPH2 resulted in a near total loss of 5-HT and its metabolite, 5-
HIAA, in both the brain and periphery. The further reduction in
brain 5HT in the DKO may suggest that TPH1 can provide some
5-HT in the absence of TPH2, either in situ or transposed from
the blood.
5-HT is detected early during brain development, suggesting its
involvement in neuronal proliferation, migration, and differenti-
ation [49]. However, we detected no structural changes in the
brain or peripheral tissues. It is notable that multiple 5-HT
receptor null mutations that have been described, e.g. 5-HT1AR,
5-HT1BR, 5- HT2CR, 5-HT5AR, 5-HT2AR, 5- HT3R, and 5-
HT6R, produce healthy animals with no overt abnormalities in
appearance or behavior [1]. Similarly, genetic disruption of SERT
also does not produce overt abnormalities [33,34].
TPH2KO and DKO mice were generally normal in appear-
ance and in many of the behavioral tests employed in this study.
This stands in strong contrast to genetic deletion of tyrosine
hydroxylase, the rate-limiting enzyme for catecholamine synthesis,
which results in perinatal lethality [50,51]. However, differences in
behavior were evident in tests sensitive to serotonergic drugs like
SSRIs and some compounds acting at 5-HT receptors. Interest-
ingly, deletion of Tph2 alone produced rather subtle behavioral
changes; these were strongly enhanced in the DKO mice.
Whether this difference was a result of Tph1 providing supple-
mentary 5-HT in brain regions where Tph2 is predominant, or
whether 5-HT normally synthesized in the brain by Tph1 plays
some particularly important role in control of behavior will require
additional studies. Despite its peripheral expression, a polymor-
phism located on TPH1 has been reported to influence the
response to antidepressant treatment [52]. Our results strongly
support targeting the 5-HT system to treat affective disorders and
the use of knockout mice as a tool to tease apart mechanisms
involved in the etiology of these disorders. The availability of mice
with genetic disruption of TPH2 and TPH1/TPH2 provides
Figure 5. Tail suspension test. (A) Immobility time in TPH2KO male
mice over days. # -p ,0.05, compared to Day 1 for the same genotype
(Tukey’s HSD following repeated measures ANOVA). (B) Immobility time
in TPH2KO male mice on day 3 of repeated TS testing. (C) Immobility
time in TPH1/TPH2 DKO. Male and female data combined on the plot
(one-way ANOVA did not reveal significant effect of sex or sex6
genotype interactions). Males: 7 WT, 6 DKO; females: 8 WT, 9 DKO. Mice
that climbed tails during testing were excluded from analysis. ** - p
,0.01 compared to WT mice.
doi:10.1371/journal.pone.0003301.g005
Figure 6. Latency to hind paw response in the hot plate acute
thermal pain test in TPH1/TPH2 DKO mice. Male and female data
combined on the plot (one-way ANOVA did not reveal significant effect
of sex or sex6genotype interactions). Males: 10 WT, 6 DKO; females: 9
WT, 12 DKO. * - p,0.05, compared to WT mice.
doi:10.1371/journal.pone.0003301.g006
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roles of serotonin in mammalian physiology and behavior.
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